Zacks Investment Research
06 Aug 2026, 16:46 UTC · 1h ago
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
06 Aug 2026, 16:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
McKesson Corporation reported Q1 fiscal 2027 adjusted EPS of $9.93, beating the Zacks Consensus Estimate of $9.44 by 5.2%. — An earnings beat combined with a 20% year-over-year increase in adjusted EPS typically drives positive short-term sentiment for the stock.
+0.40McKesson's Q1 fiscal 2027 revenues rose 8% to $105.38 billion, surpassing the consensus estimate of $104.39 billion. — Strong top-line growth exceeding expectations indicates healthy demand and operational scale.
+0.30GLP-1 medication distribution revenues increased 24% year over year to $15 billion. — High growth in a high-demand pharmaceutical category suggests a strong future growth lever for the company.
+0.30Continue reading
6 related stories
Top 3 movers · tap to explore
GAAP EPS declined 18% to $5.15 due to a $293 million redemption value adjustment in the Medical-Surgical Solutions segment. — While a GAAP decline is usually negative, this was driven by a specific accounting adjustment rather than operational failure.
-0.10Which stocks this story touches
Company reported adjusted EPS and revenue beats, raised guidance, and saw an after-hours share price increase.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
